Current Assets Alterar Data
Abbott USD 23.51B 872M 2023-06
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
AstraZeneca USD 22.5B 338M 2023-09
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Esperion Therapeutics USD 218.23M 13.9M 2023-09
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Illumina USD 2.61B 103M 2023-12
Insmed USD 929.06M 2.49M 2023-12
Ironwood Pharmaceuticals USD 233.29M 20.32M 2023-12
J&J USD 53.7B 6.86B 2023-09
MannKind USD 373.39M 147.82M 2023-12
Merck USD 31.95B 1.98B 2023-09
Moderna USD 10.32B 474M 2023-12
PTC Therapeutics USD 1.22B 678.27M 2023-12
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Thermo Fisher Scientific USD 24.59B 1.5B 2023-12
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
United Therapeutics USD 3.55B 92.1M 2023-12
Vanda Pharmaceuticals USD 533.5M 203K 2023-06



Lexicon Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.